27-year-old diabetes patient switched to cheaper Novo insulin and died – fueling US price debate

A diabetes patient in the US, who lost his health insurance and switched to a cheaper insulin from Novo Nordisk, died after going into diabetic coma. US presidential candidate Bernie Sanders blames the pharmaceutical industry but Danish doctors support Novo's insulin.

Few days before Wilkerson's death was reported, Democratic president candidate Bernie Sanders addressed the insulin price differences between the US and Canada. Photo: Rebecca Cook / Reuters / Ritzau Scanpix

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles